NCT01953315View on ClinicalTrials.gov

Muscle Progenitor Cell Therapy for Urinary Incontinence

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Urinary Incontinence
Interventions
BIOLOGICAL

Autologous Muscle Progenitor Cells

Autologous MPCs, administered via a single, direct injection into the bladder neck sphincter region

Trial Locations (2)

27103

Wake Forest Urology Clinic, Winston-Salem

27157

Wake Forest Institute for Regenerative Medicine (WFIRM), Winston-Salem

All Listed Sponsors
lead

Wake Forest University

OTHER

NCT01953315 - Muscle Progenitor Cell Therapy for Urinary Incontinence | Biotech Hunter | Biotech Hunter